US FDA withdraws warning letter to Visakhapatnam-based Divi’s Lab
The warning letter was issued in March 2017
US FDA has'closed out' a warning letter issued to Visakhapatnam-based Divi’s…
Author
Panacea Biotec gets US FDA nod to launch Prasugrel tabs
The tablets are indicated for reduction of thrombotic cardiovascular events in people with acute coronary syndrome
Panacea Biotec…
Ayurvedic products to witness threefold increase in market size
Ministry of AYUSH and Indian Council of Medicinal Research have decided to have molecular-based studies
A threefold increase in…
Biocon receives CRL from US FDA over cancer treatment biosimilar
The biosimilar Pegfilgrastim is indicated for use in treatment of cancer, jointly developed by Biocon and Mylan
Biotechnology…
Vice President inaugurates third International Conference on Yoga
The theme of this year’s conference will be ‘Yoga for Wellness’
Vice President, M Venkaiah Naidu inaugurated the two-day…
Lupin gets USFDA nod to market anti-infections tablets
The company’s product is a generic version of Pfizer's Vibra tablets
Lupin has received approval from the US health regulator to…
Strides gets inspection report for Bengaluru facility
The facility manufactures tablets, capsules, liquids, sachets, creams and ointments
Strides Shasun has received an Establishment…
Zydus Cadila’s dementia drug gets US FDA nod
The drug will be manufactured at the group’s formulations manufacturing facility at Moraiya in Ahmedabad
Zydus Cadila has…
SC bars Malvinder, Shivinder Singh from selling Fortis shares
The restriction on the brothers from diluting their stake in the hospital chain will continue till October 31, the date fixed by…
DRL settles patent row with Vivus on weight management drug
The settlement permits DRL to begin selling a generic version of Qsymia from June 2025, or earlier under certain circumstances…